Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGENOMICS INCNEO · Entity 2096 | Director | January 07, 2021 | January 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGENOMICS INC
Report date January 07, 2021 · Filed January 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Aspen Select Opportunity Fund | 1,100,000 |
Reported balance
After 2021-01-07 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-01-07 · Exercise / conversion · Acquired 100,000 · Balance 1,100,000 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | Direct | 90,218 |
Ending reported balance
After 2021-01-07 transaction · row 7
3 source rows · reconciled sequenceRow 5 · 2021-01-07 · Exercise / conversion · Acquired 10,000 · Balance 82,932 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. Row 6 · 2021-01-07 · Exercise / conversion · Acquired 3,017 · Balance 85,949 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. Row 7 · 2021-01-07 · Exercise / conversion · Acquired 4,269 · Balance 90,218 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.15 · Expires 2021-04-20 | IndirectBy Aspen Select Opportunity Fund | 0 |
Reported balance
After 2021-01-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-01-07 · Exercise / conversion · Disposed 100,000 · Balance 0 F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. On December 30, 2019, Mr. Jones transferred these options to Aspen Select Opportunity Fund, LP. F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.27 · Expires 2022-05-25 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-01-07 · Exercise / conversion · Disposed 10,000 · Balance 0 F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.60 · Expires 2023-06-01 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-01-07 · Exercise / conversion · Disposed 3,017 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.52 · Expires 2026-06-06 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-01-07 · Exercise / conversion · Disposed 4,269 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.54 · Expires 2027-05-28 | Direct | 3,448 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 3,448 |
| Common StockSEC Table I · non-derivative | IndirectBy self as Trustee for Steven and Carisa Jones 401k and Trust | 125,000 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 125,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Jones Network, LP | 30,476 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,476 |
| Common StockSEC Table I · non-derivative | IndirectShares owned in IRA, custodian accounts, and trusts for the family of Steven Jones | 40,757 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 40,757 |
Filing footnotes · ownership attribution and instrument terms
F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC.
F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. On December 30, 2019, Mr. Jones transferred these options to Aspen Select Opportunity Fund, LP.
F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2019 Filed Mar 1, 2019 01:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 32,371 | $18.78 | $607,927.38 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 150,000 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 01:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 252,881 | $18.90 | $4,779,450.90 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,900,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 01:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 1,000 | $19.24 | $19,240.00 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 47,657 Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 01:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 1,900 | $19.27 | $36,613.00 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 182,371 Read SEC document |
| February 26, 2019 Filed Mar 1, 2019 01:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 11,721 | $19.24 | $225,512.04 |
DisclosureSEC source: 0001077183-19-000018 · wf-form4_155140353500112.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,152,881 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 14, 2018 Filed Nov 15, 2018 00:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 1,729 | $16.50 | $28,528.50 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 8 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 184,271 Read SEC document |
| November 14, 2018 Filed Nov 15, 2018 00:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 3,824 | $16.50 | $63,096.00 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,164,602 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 00:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 4,000 | $16.66 | $66,640.00 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 186,000 Read SEC document |
| November 13, 2018 Filed Nov 15, 2018 00:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 31,574 | $16.69 | $526,970.06 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,168,426 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 12, 2018 Filed Nov 15, 2018 00:30 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 100,000 | $16.66 | $1,666,000.00 |
DisclosureSEC source: 0001077183-18-000117 · wf-form4_154224184012849.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 2,200,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 01, 2018 Filed Aug 1, 2018 23:56 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 119,948 | $14.00 | $1,679,272.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,300,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 23:56 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 38,952 | $14.00 | $545,328.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,419,948 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 23:56 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 41,100 | $14.01 | $575,811.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,458,900 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 23:56 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 3,500 | $14.00 | $49,000.00 |
DisclosureSEC source: 0001077183-18-000066 · wf-form4_153316777961269.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 48,657 Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 21:29 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 89,688 | $14.04 | $1,259,219.52 |
DisclosureSEC source: 0001077183-18-000060 · wf-form4_153004855347324.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,500,000 F1 · price: Averages of prices sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 19, 2018 Filed Jun 19, 2018 22:54 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 158,312 | $13.32 | $2,108,066.76 |
DisclosureSEC source: 0001077183-18-000055 · wf-form4_152944885560971.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,589,688 F1 · price: Average of prices sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 22:54 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 2,000 | $13.25 | $26,500.00 |
DisclosureSEC source: 0001077183-18-000055 · wf-form4_152944885560971.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,748,000 F1 · price: Average of prices sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:42 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-18-000042 · wf-form4_152823489940312.xml · derivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,017 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:42 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 230,533 | $12.12 | $2,794,059.96 |
DisclosureSEC source: 0001077183-18-000042 · wf-form4_152823489940312.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,750,000 F1 · price: Average price of shares sold. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:42 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 6,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-18-000042 · wf-form4_152823489940312.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,815 Read SEC document |
| May 31, 2018 Filed May 31, 2018 21:54 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 17,548 | $11.68 | $204,960.64 |
DisclosureSEC source: 0001077183-18-000036 · wf-form4_152780363232002.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,980,533 F1 · price: Average price of shares sold F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| May 30, 2018 Filed May 31, 2018 21:54 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 37,619 | $11.72 | $440,894.68 |
DisclosureSEC source: 0001077183-18-000036 · wf-form4_152780363232002.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 2,998,081 F1 · price: Average price of shares sold F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| May 29, 2018 Filed May 31, 2018 21:54 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 114,300 | $11.67 | $1,333,881.00 |
DisclosureSEC source: 0001077183-18-000036 · wf-form4_152780363232002.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Oppurtunity Fund Disclosed balance after: 3,035,700 F1 · price: Average price of shares sold F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 14, 2017 Filed Dec 14, 2017 21:38 UTC | NEOGENOMICS INC NEO · Entity 2096 | GiftCommon Stock | 20,000 | $9.06 | $181,200.00 |
DisclosureSEC source: 0001209191-17-065689 · doc4.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,251 Read SEC document |
| June 27, 2017 Filed Jun 28, 2017 22:09 UTC | NEOGENOMICS INC NEO · Entity 2096 | OtherCommon Stock | 190,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-042170 · doc4.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 190,000 F2 · price: Transaction represents non-market transfer from Steven and Carisa Jones Defined Benefit Plan to Steven and Carisa Jones 401k Plan and Trust Read SEC document |
| June 27, 2017 Filed Jun 28, 2017 22:09 UTC | NEOGENOMICS INC NEO · Entity 2096 | OtherCommon Stock | 190,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-042170 · doc4.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones Defined Benefit Plan and Trust Disclosed balance after: 190,000 F2 · price: Transaction represents non-market transfer from Steven and Carisa Jones Defined Benefit Plan to Steven and Carisa Jones 401k Plan and Trust Read SEC document |
| May 25, 2017 Filed May 31, 2017 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantRestricted Stock · Derivative | 8,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036316 · doc4.xml · derivative · entry 9 JONES STEVEN C · CIK 0001518732 · Executive VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,667 Underlying: Common Stock · 8,667 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F6 · derivative.exercise_date: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018. F7 · derivative.expiration_date: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date. Read SEC document |
| May 25, 2017 Filed May 31, 2017 01:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option · Derivative | 10,000 | $7.27 Strike: $7.27 | $72,700.00 |
DisclosureSEC source: 0001209191-17-036316 · doc4.xml · derivative · entry 8 JONES STEVEN C · CIK 0001518732 · Executive VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2022-05-25 F4 · derivative.exercise_date: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date. Read SEC document |
| December 27, 2016 Filed Dec 27, 2016 21:18 UTC | NEOGENOMICS INC NEO · Entity 2096 | GiftCommon Stock | 20,000 | $8.92 | $178,400.00 |
DisclosureSEC source: 0001209191-16-156818 · doc4.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Executive VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,251 Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 21:11 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleWarrants · Derivative | 112,500 | $1.50 Strike: $1.50 | $168,750.00 |
DisclosureSEC source: 0001209191-16-141827 · doc4.xml · derivative · entry 10 JONES STEVEN C · CIK 0001518732 · Executive VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,500 shares Expires 2017-05-03 F4 · kind: Warrants were sold to an unaffiliated third party and remain subject to exercise. F5 · derivative.exercise_date: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 21:11 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleWarrants · Derivative | 112,500 | $1.50 Strike: $1.50 | $168,750.00 |
DisclosureSEC source: 0001209191-16-141827 · doc4.xml · derivative · entry 9 JONES STEVEN C · CIK 0001518732 · Executive VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,500 shares Expires 2017-05-03 F4 · kind: Warrants were sold to an unaffiliated third party and remain subject to exercise. F5 · derivative.exercise_date: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 21:11 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleWarrants · Derivative | 225,000 | $1.50 Strike: $1.50 | $337,500.00 |
DisclosureSEC source: 0001209191-16-141827 · doc4.xml · derivative · entry 8 JONES STEVEN C · CIK 0001518732 · Executive VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 225,000 shares Expires 2017-05-03 F4 · kind: Warrants were sold to an unaffiliated third party and remain subject to exercise. F5 · derivative.exercise_date: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.